Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors

Koji Sasaki, Hagop M. Kantarjian, Nicholas J. Short, Bachar Samra, Joseph D. Khoury, Rashmi Kanagal Shamanna, Marina Konopleva, Nitin Jain, Courtney D. DiNardo, Rita Khouri, Guillermo Garcia-Manero, Tapan M. Kadia, William G. Wierda, Issa F. Khouri, Partow Kebriaei, Rohtesh S. Mehta, Richard E. Champlin, Rebecca Garris, Cora Marie Cheung, Naval DaverPhilip A. Thompson, Musa Yilmaz, Farhad Ravandi, Elias Jabbour

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences